Specially, in non‐small cell lung cancer (NSCLC), overexpression of RCN1 correlates with poor prognosis and progression12 and the efficacy of platinum‐based adjuvant chemotherapy relates with co‐expression of RCN1 and GST‐π.13 This evidence concerns the gene RCN1 and non-small cell lung carcinoma.